| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 36,437 | 39,559 | ||
| Short-term investments | 142,201 | 144,531 | ||
| Accounts receivable, net | 32,962 | 34,891 | ||
| Inventories | 49,289 | 52,249 | ||
| Prepaid expenses and other current assets | 4,478 | 4,348 | ||
| Total current assets | 265,367 | 275,578 | ||
| Restricted cash | 3,329 | 3,329 | ||
| Property and equipment, net | 5,254 | 6,166 | ||
| Operating lease right-of-use assets | 2,767 | 3,168 | ||
| Other assets | 538 | 560 | ||
| Total assets | 277,255 | 288,801 | ||
| Accounts payable | 1,724 | 1,445 | ||
| Accrued compensation and related benefits | 10,855 | 9,789 | ||
| Accrued expenses and other current liabilities | 6,692 | 8,518 | ||
| Accrued warranty liability | 1,363 | 1,239 | ||
| Deferred revenue, current | 14,900 | 14,009 | ||
| Operating lease liabilities, current | 1,912 | 1,909 | ||
| Total current liabilities | 37,446 | 36,909 | ||
| Accrued interest | 0 | 0 | ||
| Deferred revenue | 676 | 587 | ||
| Operating lease liabilities | 1,244 | 1,707 | ||
| Term loan | 95,524 | 94,814 | ||
| Total liabilities | 134,890 | 134,017 | ||
| Preferred stock, 0.001 par value 5,000 shares authorized as of september 30, 2025 and december 31, 2024 21 and 0 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 3,841 | 3,841 | ||
| Common stock, 0.001 par value 300,000 shares authorized as of september 30, 2025 and december 31, 2024 17,809 and 3,530 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 18 | 18 | ||
| Additional paid-in capital | 1,290,234 | 1,284,923 | ||
| Accumulated other comprehensive loss | 157 | 49 | ||
| Accumulated deficit | -1,151,885 | -1,134,047 | ||
| Total stockholders' equity | 142,365 | 154,784 | ||
| Total liabilities and stockholders' equity | 277,255 | 288,801 | ||
Outset Medical, Inc. (OM)
Outset Medical, Inc. (OM)